| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal Results
|
Brierley, Bente Brattland
|
|
2015
|
16 |
15 |
p. 1459-1460
|
artikel
|
| 2 |
Attenuating pain flare: a new role for an old therapy?
|
Laird, Barry J
|
|
2015
|
16 |
15 |
p. 1440-1441
|
artikel
|
| 3 |
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial
|
Tournigand, Christophe
|
|
2015
|
16 |
15 |
p. 1493-1505
|
artikel
|
| 4 |
Busulfan-based conditioning regimens: not all partners are equal
|
Giralt, Sergio
|
|
2015
|
16 |
15 |
p. 1448-1449
|
artikel
|
| 5 |
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial
|
Rambaldi, Alessandro
|
|
2015
|
16 |
15 |
p. 1525-1536
|
artikel
|
| 6 |
Cabozantinib and nivolumab for renal cell carcinoma
|
Worley, Luke
|
|
2015
|
16 |
15 |
p. e531
|
artikel
|
| 7 |
Cancer Drugs Fund failed to collect patient outcomes
|
Baker, Holly
|
|
2015
|
16 |
15 |
p. e529
|
artikel
|
| 8 |
Cancer incidence in indigenous people in Australia, New Zealand, Canada, and the USA: a comparative population-based study
|
Moore, Suzanne P
|
|
2015
|
16 |
15 |
p. 1483-1492
|
artikel
|
| 9 |
Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial
|
Symonds, R Paul
|
|
2015
|
16 |
15 |
p. 1515-1524
|
artikel
|
| 10 |
Cells and stanzas
|
Ranscombe, Peter
|
|
2015
|
16 |
15 |
p. 1461-1462
|
artikel
|
| 11 |
Chemotherapy plus ponatinib: a new standard for Ph-positive ALL?
|
Thomas, Xavier
|
|
2015
|
16 |
15 |
p. 1451-1453
|
artikel
|
| 12 |
Clinical implications for cediranib in advanced cervical cancer
|
Tewari, Krishnansu S
|
|
2015
|
16 |
15 |
p. 1447-1448
|
artikel
|
| 13 |
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
|
Jabbour, Elias
|
|
2015
|
16 |
15 |
p. 1547-1555
|
artikel
|
| 14 |
Combination therapy in kidney cancer: the next revolution?
|
Buti, Sebastiano
|
|
2015
|
16 |
15 |
p. 1441-1442
|
artikel
|
| 15 |
Correction to Lancet Oncol 2015; 16: 1013
|
|
|
2015
|
16 |
15 |
p. e528
|
artikel
|
| 16 |
Correction to Lancet Oncol 2015; 16: 1143
|
|
|
2015
|
16 |
15 |
p. e528
|
artikel
|
| 17 |
Correction to Lancet Oncol 2015; 16: 1289
|
|
|
2015
|
16 |
15 |
p. e528
|
artikel
|
| 18 |
Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial
|
Chow, Edward
|
|
2015
|
16 |
15 |
p. 1463-1472
|
artikel
|
| 19 |
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas
|
Sarkozy, Clémentine
|
|
2015
|
16 |
15 |
p. e555-e567
|
artikel
|
| 20 |
Early rectal cancer: opening the door to change
|
Glynne-Jones, Robert
|
|
2015
|
16 |
15 |
p. 1449-1451
|
artikel
|
| 21 |
Endometrial cancer with progestagen and oestrogen oral contraceptives
|
Grant, Ellen C G
|
|
2015
|
16 |
15 |
p. e527
|
artikel
|
| 22 |
Equitable cancer control: better data needed for indigenous people
|
Sarfati, Diana
|
|
2015
|
16 |
15 |
p. 1442-1444
|
artikel
|
| 23 |
Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial
|
Perez, Edith A
|
|
2015
|
16 |
15 |
p. 1556-1568
|
artikel
|
| 24 |
2015 European Cancer Congress
|
Yaqub, Farhat
|
|
2015
|
16 |
15 |
p. 1457-1458
|
artikel
|
| 25 |
Fatigue and mortality: from description to action
|
Gotay, Carolyn
|
|
2015
|
16 |
15 |
p. 1445-1446
|
artikel
|
| 26 |
21-gene assay identifies patients who can avoid chemotherapy
|
Baker, Holly
|
|
2015
|
16 |
15 |
p. e531
|
artikel
|
| 27 |
High genetic heterogeneity in some breast cancer tumours
|
Burki, Talha Khan
|
|
2015
|
16 |
15 |
p. e529
|
artikel
|
| 28 |
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
|
Okada, Hideho
|
|
2015
|
16 |
15 |
p. e534-e542
|
artikel
|
| 29 |
Inflammatory breast cancer: unique biological and therapeutic considerations
|
Woodward, Wendy A
|
|
2015
|
16 |
15 |
p. e568-e576
|
artikel
|
| 30 |
Join us at The Lancet Clinic
|
Kleinert, Sabine
|
|
2015
|
16 |
15 |
p. 1456
|
artikel
|
| 31 |
Kin, career, and cancer
|
Lucas, Catherine
|
|
2015
|
16 |
15 |
p. 1462
|
artikel
|
| 32 |
Laparoscopic resection not better in rectal cancer
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
15 |
p. e533
|
artikel
|
| 33 |
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
|
Motzer, Robert J
|
|
2015
|
16 |
15 |
p. 1473-1482
|
artikel
|
| 34 |
Maintenance therapy for metastatic colorectal cancer
|
Ciardiello, Fortunato
|
|
2015
|
16 |
15 |
p. 1444-1445
|
artikel
|
| 35 |
Miss You Already
|
Zajanckauskaite, Estera
|
|
2015
|
16 |
15 |
p. 1460-1461
|
artikel
|
| 36 |
Morcellation of uterine leiomyomas: a plea for patient triage
|
Amant, Frédéric
|
|
2015
|
16 |
15 |
p. 1454-1456
|
artikel
|
| 37 |
Multifunctional receptor-targeting antibodies for cancer therapy
|
Zhu, Yanni
|
|
2015
|
16 |
15 |
p. e543-e554
|
artikel
|
| 38 |
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial
|
Garcia-Aguilar, Julio
|
|
2015
|
16 |
15 |
p. 1537-1546
|
artikel
|
| 39 |
Overtreatment in stage IV lung cancer in the USA
|
Baker, Holly
|
|
2015
|
16 |
15 |
p. e532
|
artikel
|
| 40 |
Palliative chemotherapy for patients with breast cancer
|
Saloustros, Emmanouil
|
|
2015
|
16 |
15 |
p. 1453-1454
|
artikel
|
| 41 |
Preoperative MRI in breast cancer
|
Burki, Talha Khan
|
|
2015
|
16 |
15 |
p. e530
|
artikel
|
| 42 |
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study
|
Efficace, Fabio
|
|
2015
|
16 |
15 |
p. 1506-1514
|
artikel
|
| 43 |
Radiotherapy in the elderly and frail with glioblastoma
|
Baker, Holly
|
|
2015
|
16 |
15 |
p. e530
|
artikel
|
| 44 |
Rethinking traditional Chinese medicines for cancer
|
The Lancet Oncology,
|
|
2015
|
16 |
15 |
p. 1439
|
artikel
|
| 45 |
Urgent referral pathway alters cancer survival
|
Tanday, Sanjay
|
|
2015
|
16 |
15 |
p. e532
|
artikel
|
| 46 |
Variation in palliative care standards worldwide
|
Burki, Talha Khan
|
|
2015
|
16 |
15 |
p. e533
|
artikel
|
Tijdschrift beschrijving